Previous Article | Next Article 
Journal of Clinical Microbiology, April 2008, p. 1246-1251, Vol. 46, No. 4
0095-1137/08/$08.00+0 doi:10.1128/JCM.01621-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Genetic Diversity of Mycobacterium avium Isolates Recovered from Clinical Samples and from the Environment: Molecular Characterization for Diagnostic Purposes
Julio Álvarez,1
Ignacio Gómez García,2
Alicia Aranaz,1*
Javier Bezos,1
Beatriz Romero,1
Lucía de Juan,1
Ana Mateos,1
Enrique Gómez-Mampaso,3 and
Lucas Domínguez1
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain,1
Servicio de Urología, Hospital Virgen de la Salud, 45004 Toledo, Spain,2
Servicio de Microbiología, Hospital Ramón y Cajal, IMSALUD, 28034 Madrid, Spain3
Received 14 August 2007/
Returned for modification 2 December 2007/
Accepted 4 February 2008

ABSTRACT
Isolation of
Mycobacterium avium complex (MAC) organisms from
clinical samples may occur in patients without clinical disease,
making the interpretation of results difficult. The clinical
relevance of MAC isolates from different types of clinical samples
(
n = 47) from 39 patients in different sections of a hospital
was assessed by comparison with environmental isolates (
n =
17) from the hospital. Various methods for identification and
typing (commercial probes, phenotypic characteristics, PCR for
detection of IS
1245 and IS
901, sequencing of the
hsp65 gene,
and pulsed-field gel electrophoresis) were evaluated. The same
strain was found in all the environmental isolates, 21 out of
23 (91.3%) of the isolates cultured from urine samples, and
5 out of 19 (26.3%) isolates from respiratory specimens. This
strain did not cause disease in the patients. Testing best characterized
the strain as
M. avium subsp.
hominissuis, with the unusual
feature that 81.4% of these isolates lacked the IS
1245 element.
Contamination of certain clinical samples with an environmental
strain was the most likely event; therefore, characterization
of the environmental mycobacteria present in health care facilities
should be performed to discard false-positive isolations in
nonsterile samples, mainly urine samples. Molecular techniques
applied in this study demonstrated their usefulness for this
purpose.

INTRODUCTION
The clinical relevance of
Mycobacterium avium complex (MAC)
has increased in recent decades because of the rising population
of immunocompromised individuals due to longer life expectancy,
immunosuppressive chemotherapy, and AIDS pandemia (
28). In AIDS
patients, MAC is the most common nontuberculous mycobacteria
causing disease, especially in developed countries, and usually
produces disseminated infections (
8,
16). However, MAC also
causes infection in immunocompetent individuals with underlying
pulmonary disease and in children with lymphadenitis or cystic
fibrosis (
10,
14,
16).
Mycobacterial species comprised in MAC have undergone reorganization based on biological, serological, and molecular characteristics (Table 1). The most important species causing disease in humans can be differentiated using PCR-based methods for the detection of the presence/absence of insertion sequences (IS): M. avium subsp. avium (37) presents IS901 (7, 21, 27) and low copy numbers of IS1245 (13, 17), M. avium subsp. hominissuis (25) usually harbors high numbers of IS1245 but no IS901 (25), and Mycobacterium intracellulare (32, 42) presents neither IS901 nor IS1245 (2). Other MAC species include M. avium subsp. paratuberculosis, whose involvement in Crohn's disease is still under discussion (9), and M. avium subsp. silvaticum (37).
In spite of the environmental colonization and rising prevalence
of disease due to members of MAC, the epidemiology of infection
is still not clear. The routes of transmission have not been
unambiguously identified, and human-to-human transmission has
not been demonstrated. Mycobacteria belonging to MAC have also
been detected in a wide range of animal species, including birds
(mainly
M. avium subsp.
avium) (
27), pigs (more frequently
M. avium subsp.
hominissuis), (
19), and small vertebrates (
11).
The environment is the most likely source of infection for humans, as M. avium is considered a ubiquitous organism and has been isolated from water (1), soil, and dust (15). Water distribution systems have been reported as a possible source of infection in hospitals, homes, and commercial buildings (1, 41); moreover, hospital water can also contaminate samples of uninfected patients, making the clinical significance of the MAC isolation unclear (38).
Current diagnosis is based on probes or PCR tests that occasionally are not able to discriminate between MAC species or subspecies. Several molecular biology techniques can be used for epidemiological studies in order to establish measures to control the dissemination of the infection. For this purpose, restriction fragment length polymorphism (RFLP) using IS1245 as a probe (40) has been widely used; however, the effectiveness of IS1245 RFLP is limited in M. avium strains harboring a low number of IS1245 copies.
Pulsed-field gel electrophoresis (PFGE) has also been shown to be a useful technique for assessing the relatedness of strains among MAC (24). Nevertheless, PFGE requires a large amount of bacterial DNA for good visualization of the patterns. Other characterization techniques include sequencing of the 65-kDa heat shock protein gene (hsp65) (29, 39) and of the internal transcribed spacers (ITS) (26).
The aim of this study was to characterize the environmental strains of MAC present in a hospital using different molecular tests (IS1245 and IS901 detection, hsp65 sequencing, and PFGE analysis) and to compare them with clinical isolates from patients from the same hospital in order to evaluate the possibility of nosocomial infections or contamination of samples.

MATERIALS AND METHODS
A total of 64 isolates belonging to MAC from a public hospital
were analyzed. This hospital covers a population of 525,000
inhabitants and is located in Madrid (Spain). Forty-seven isolates
were recovered from clinical samples obtained from patients
from different sections of the hospital. The other 17 isolates
were cultured from several environmental sources (tap water
from various floors of the hospital and containers for the collection
of urine samples). All the isolates were cultured in the period
between 2002 and 2005.
Clinical M. avium isolates.
Forty-seven MAC isolates were recovered from 12 AIDS patients and 27 patients not infected with human immunodeficiency virus (HIV). Initially, all patients showed clinical syndromes compatible with mycobacterial diseases (pneumonia, meningitis, pericarditis, etc.) though active mycobacterial infection was afterwards confirmed in only 13 patients based on clinical criteria. The isolates were processed according to Tacquet and Tison (34) and cultured in Coletsos medium (BioMedics S.L., Tres Cantos, Madrid, Spain). Among these 47 isolates, 13 were sequential isolates cultured from identical or nonidentical sites from five patients (patient numbers 17, 18, 19, 35, and 36), and the rest were single isolates from 34 patients. Thirty-eight isolates were cultured from admitted patients, while the remaining nine isolates were obtained from nonadmitted patients. Most of the isolates were cultured from nonsterile sites (urine, n = 23; sputum, n = 19) except for five isolates (blood, n = 3; liver biopsy, n = 1; bone marrow, n = 1).
Environmental M. avium isolates.
Eleven isolates were cultured from the intermediate containers used for the collection of urine samples in disabled patients and six were from tap water taken from the different patient's rooms at the hospital. Fifty milliliters of water was collected from the water taps of the patients' rooms into sterile tubes; the intermediate containers were cleaned following the standard procedure and then rinsed with 50 ml of sterile water that was afterwards collected into sterile tubes. These samples were centrifuged at 3,500 rpm for 30 min; the pellet was decontaminated according to Tacquet and Tisson (34) and centrifuged again at 3,500 rpm. The pellet was then inoculated into Löwestein-Jensen medium supplemented with amphotericin (400 mg/liter), nalidixic acid (35 mg/liter), and lincomycin (2 mg/liter) and into Coletsos (BioMedics S.L.) medium. Media were incubated at 36°C for up to two months.
Primary identification.
Isolates were identified as MAC members by using the commercial AccuProbe MAC culture identification kit (Gen-Probe, CA) and by phenotypical characteristics: growth temperature at 25°C, 36°C, and 43°C; tellurite reduction, Tween 80 hydrolysis; nitrate reduction test; and sodium chloride tolerance (18).
PCR analysis.
Bacterial cells were suspended in 200 µl of sterile water and boiled for 10 min; then they were centrifuged, and the supernatant was used as the DNA template for the PCRs. The identification of the isolates as M. avium or M. intracellulare was carried out by PCRs aimed at specific regions of the 16S rDNA (5, 43). PCR amplification of the insertion sequences IS901 and IS1245 was performed as described previously (13, 20). The PCR and sequencing of the hsp65 gene were carried out as described previously in M. avium isolates (29, 35, 39).
For confirmation of the identity of the IS1245-negative M. avium isolates, 12 isolates were randomly selected (seven from urine samples and five from environmental sources) and subjected to PCR amplification and restriction enzyme analysis (REA) of IS1311; amplified DNA was digested with the restriction enzymes HinfI and MseI (New England Biolabs, Hitchin, Hertfordshire, United Kingdom) as described elsewhere (23). Analysis of the 16S rDNA and 16S-23S rDNA ITS sequences was performed in four isolates (two environmental cultures and two isolates from urine samples) (5, 31). PCR primers used in all reactions are described in Table 2. Positive and negative controls were included in each batch of tests.
PFGE analysis.
M. avium subsp.
hominissuis isolates were typed by PFGE analysis
as described before (
24). Briefly, bacterial cells were cast
into low-melting-point agarose plugs and lysed with lysozyme
(1 mg/ml), 1% sodium dodecyl sulfate, and proteinase K (1 mg/ml).
Plugs containing DNA were digested with 20 U of XbaI for 4 h
(New England Biolabs). The digested DNA was loaded in a 1% agarose
gel and run in Tris-borate-EDTA buffer. PFGE was performed using
a CHEF-DR III System (Bio-Rad Laboratories Ltd.) at 14°C
for 20 h at 200 V. Gels were stained with ethidium bromide and
photographed under UV light. The PFGE patterns obtained were
interpreted as proposed by Tenover et al. (
36); isolates were
considered closely related if differences of no more than 2
to 3 bands were observed between the obtained PFGE profiles.

RESULTS
PCR results.
All 64 isolates were identified as belonging to the
Mycobacterium genus based on the results of the AccuProbe test and on the
detection of specific regions of the 16S rDNA. Fifty-five isolates
were identified as
M. avium, and nine were identified as
M. intracellulare by detection of a specific 16S rDNA fragment.
The IS
901 PCR gave negative results in all 55
M. avium isolates
under study. IS
1245 was detected in 11
M. avium isolates, all
from clinical samples (Table
3, Table
4, and Table
5).
View this table:
[in this window]
[in a new window]
|
TABLE 3. Characterization of M. avium subsp. hominissuis isolates cultured from urine samples (n = 23) from 20 patients
|
View this table:
[in this window]
[in a new window]
|
TABLE 4. Characterization of M. avium subsp. hominissuis isolates cultured from sputum samples (n = 11) from 11 patients
|
View this table:
[in this window]
[in a new window]
|
TABLE 5. Characterization of M. avium subsp. hominissuis isolates cultured from sterile samples (n = 4) from three patients
|
Clinical isolates.
The 23 isolates cultured from urine samples from 20 patients
were identified as belonging to MAC, but only two of them harbored
IS
1245 (Table
3). Sequencing of the 3' end of the
hsp65 gene
was performed on 21 isolates, 19 IS
1245-negative isolates, and
the 2 IS
1245-positive isolates. The code 2
hsp65 sequevar (
39),
a typical sequevar of
M. avium subsp.
hominissuis, was obtained
in all 19 isolates lacking IS
1245. The two IS
1245-positive isolates
contained a code 1 sequevar. All of the IS
1245-negative code
2 isolates were cultured from samples from patients who were
later considered by clinical criteria not to be infected with
MAC (Table
3). The two patients from whom the IS
1245-positive
isolates came were the only ones considered infected by MAC.
In the first case,
M. avium was also isolated from blood and
sputum of the same patient; all three isolates shared the same
code 1
hsp65 sequevar, and the two PFGE-typed isolates shared
the same profile. Thus, this patient was thought to have a disseminated
infection. In the second case, the patient had a history of
repetitive
M. avium isolations in urine samples obtained using
a catheter; the strain isolated presented a code 1 in the
hsp65 analysis, and its PFGE profile was considered unrelated to all
the others obtained in the study.
Nineteen MAC isolates were cultured from sputum samples of 17 patients. Eight isolates were identified as M. intracellulare, seven of which were causing disease in immunocompetent patients, while one isolate could not be associated with any pathology. The remaining 11 isolates were identified as M. avium (Table 4), and four of these isolates were associated with disease in the patients (three of these isolates harbored IS1245 and contained different hsp65 sequevars [codes 1, 2, and 9], and one was IS1245 negative and contained a code 15 hsp65 sequevar [GenBank accession no. EU085419]). Seven M. avium isolates came from patients not infected with MAC, and five were IS1245 negative and contained a code 2 hsp65 sequevar. The other two were IS1245 positive and showed different hsp65 codes (1 and 2).
The three isolates from blood samples, two from the same patient, contained the IS1245 element and had the code 1 hsp65 sequevar. The strain coming from a liver biopsy presented the IS1245 element and had a code 3 hsp65 sequevar (Table 5). Finally, the isolate from the bone marrow sample was identified as M. intracellulare. All of the isolates cultured from sterile samples were causing disease.
Environmental isolates.
All of the 17 isolates were identified as M. avium. The IS1245 element was absent in all of them. The sequencing of the hsp65 3' end revealed the same sequevar (code 2) in 16 strains (no signal was obtained in 1 strain).
IS1311 REA.
In the 12 IS1245-negative M. avium isolates analyzed by means of the IS1311 PCR and subsequent digestion with HinfI and MseI, the expected fragments for the M. avium 285- and 323-bp bands and 419- and 189-bp bands, respectively, were obtained; thus, this confirmed the identification of the IS1245-negative isolates as M. avium strains.
Four IS1245-negative isolates were also subjected to 16S rDNA and ITS sequencing, and identical sequences were obtained for the four strains in both fragments. The 16S rDNA sequence from the four isolates showed one single-nucleotide polymorphism (T instead of G at nucleotide 445) with the M. avium 104 strain sequence (GenBank accession CP000479). The ITS sequence obtained matched perfectly with the Mav-A sequevar described previously (6, 12).
PFGE results.
Thirty-eight isolates yielded readable patterns after digestion with the XbaI restriction enzyme: 29 from clinical samples (21 from urine samples, 6 from sputum samples, and 1 from a blood and a liver biopsy sample) (Table 3, Table 4, and Table 5) and 9 from environmental samples. Nine unrelated patterns were observed. All of the environmental isolates, 19 out of 21 isolates from urine, and 3 out of 6 from sputum yielded identical (pattern A) or closely related (A*) patterns. All of these isolates also contained a code 2 hsp65 sequevar and, with the exception of two isolates cultured from sputum samples, harbored no copies of IS1245. A second pattern (pattern B) was found in two isolates coming from sputum and urine samples from the same patient. The remaining isolates showed unrelated patterns.

DISCUSSION
This report describes the usefulness of several molecular techniques
in the correct diagnosis and study of the epidemiology of MAC
infections. Genetic tools, including commercial kits, for identification
of MAC members are now available to mycobacteriology laboratories.
Still, many clinical laboratories just identify the isolates
as MAC members, as the treatment is the same for all MAC infections
(
4). Therefore, only incomplete epidemiological studies can
be carried out. In our study, a combination of techniques was
required to precisely identify the isolates to a subspecies
level and to assess their relatedness.
IS1245 is considered to be highly specific to M. avium (13), so it is commonly used for identification and typing (40). However, M. avium strains lacking IS1245 were first described by Ritacco et al. (30) and were later reported as being isolated from human or animal sources (3, 19, 22); nonetheless, they were considered a rare finding and were always found in low proportions compared with the IS1245-positive strains. In most cases, characterization of IS1245-negative isolates is based only on commercial probes that might not identify the isolate unambiguously to the species-subspecies level. In our study, the identity of the M. avium strains lacking IS1245 was confirmed by 16S rDNA, ITS, and hsp65 sequencing and by IS1311 REA and represented 81.8% of all M. avium isolates cultured, regardless of the source. The hsp65 sequencing was a useful tool for confirmation of species identification of IS1245-negative M. avium isolates as previously described (4). Though PFGE and IS1245 RFLP had been shown to have similar discriminative powers, PFGE is the only applicable typing technique for these isolates.
Molecular tests demonstrated that the same M. avium strain lacking IS1245, with a code 2 hsp65 sequevar and a certain PFGE profile, pattern A, was isolated from all environmental samples, most of the urine samples (21 out of 23, or 91.3%), and several respiratory specimens (5 out of 19, or 26.3%).
The clinical significance of the isolation of MAC members from nonsterile human samples is a controversial issue. In this way, MAC-positive culture has been shown to occur in respiratory specimens from patients without clinical disease (38); this could happen due to contamination of the sample or transient or persistent colonization. Likewise, results of direct observation of mycobacteria by acid-fast staining in urine samples should be interpreted carefully.
The molecular characterization correlated with clinical significance in that the 18 patients in whose urine the IS1245-negative code 2 hsp65 sequevar was found were considered not infected by MAC by clinical criteria. On the other hand, the two M. avium isolates cultured from urine samples that harbored IS1245 and had a code 1 hsp65 sequevar came from two patients likely to have an M. avium infection: the first patient was thought to have a disseminated infection, and the second had a history of repetitive M. avium isolations in urine.
The explanation of the IS1245-negative code 2 hsp65 sequevar isolations from certain urine samples could be attributed to the collection method: in this hospital, patients collect their urine samples into sterile receptacles, but intermediate containers might be used when the patient is handicapped. These intermediate containers are washed with tap water and soap after every use but not always sterilized while used by the same patient. The environmental isolates were cultured from the sediment obtained from the intermediate containers or from the taps of the patient's rooms. Thus, it is likely that urine samples collected using these containers would be contaminated by the environmental MAC strains. MAC members have been shown to grow in biofilms, increasing their resistance to disinfection methods such as chlorination (33); the most prevalent strain found in our study might persistently colonize the water supply system of the hospital as it was isolated from water samples from different floors of the hospital during a 3-year period.
The possibility of contamination of urine samples during the collecting process in the hospital is enhanced by the fact that, in samples collected in patient's houses, the recovery rate of M. avium is lower. In this context, in the period 1996 to 2003, 3,195 urine samples from admitted patients were cultured for the presence of mycobacteria, and 79 (2.47%) were positive. In the same period, 3,486 samples from outpatients were also collected and analyzed, and only 4 (0.11%) yielded positive isolation of MAC (E. Gomez-Mampaso, unpublished data).
Unlike the urine sample results, in the sputum samples the IS1245-negative code 2 hsp65 sequevar strain represented only 5 out of the 19 MAC isolates recovered (again, they were considered as nonpathogenic). Sputum samples are collected directly into sterile receptacles, and therefore contamination of these samples is unlikely to occur; however, patients can be exposed to aerosols from shower and tap water from the bathrooms. If the water harbors M. avium, it could be a possible source of contamination.
Regarding M. intracellulare, eight isolates were recovered from respiratory samples and one from bone marrow. All except one (isolated from sputum) were found to be disease causing, highlighting the importance of this bacteria as a human pathogen.
Hospital water has been reported as a possible source of MAC infection (1, 38, 41). In these studies some degree of relationship was found between environmental M. avium and strains isolated from clinical samples (sputum, blood, or bone marrow). However, tap water was not usually added during the collection of the samples from which the cultures were recovered, and therefore contamination with environmental M. avium strains was considered unlikely. In our setting, we consider more possible a contamination of certain samples due to an incorrect collection method in some special cases of disabled patients. This hypothesis is supported by the fact that most of the patients (15 out of 20, or 75%) with positive isolations of MAC in urine were immunocompetent and were considered afterwards uninfected by MAC based on further medical analysis. Therefore, the environmental strain seemed to have low virulence since, even though it was widely distributed, it was not found to be pathogenic in any patient. However, the risk of infection by this strain cannot be ruled out, particularly in the case of HIV patients. To our knowledge, there are no studies that correlate the absence of IS1245, the hsp65 sequevar, the PFGE pattern, and virulence, and therefore further research is needed to find out if these results can be extrapolated to other settings.
In summary, these results highlight the possibility of false-positive acid-fast staining or isolations of MAC members in nonsterile clinical samples, especially in the case of urine specimens. Therefore, it is important to characterize the environmental mycobacteria present in the facilities in order to exclude false-positive isolation in samples susceptible to contamination. For this purpose a combination of molecular techniques is required to correctly characterize MAC isolates. In our study we have demonstrated the presence of a particular strain persistently colonizing the water supply system and representing a potential source of contamination of samples and of infection in patients.

ACKNOWLEDGMENTS
This research was funded by project AGL2005-07792 of the Spanish
Ministry of Science and Technology and European Commission QLRT-2000-01420.
J.A. was the recipient of a grant (AP2002-0141) of the Ministry
of Education and Culture.
We thank the staff of the SADNA (C.I.B. Madrid) for sequencing. We are grateful to Matthew Gilmour for careful revision of the manuscript.

FOOTNOTES
* Corresponding author. Mailing address: Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain. Phone: 34 91 3943721. Fax: 34 91 3943795. E-mail:
alaranaz{at}vet.ucm.es 
Published ahead of print on 13 February 2008. 

REFERENCES
1 - Aronson, T., A. Holtzman, N. Glover, M. Boian, S. Froman, O. G. Berlin, H. Hill, and G. Stelma, Jr. 1999. Comparison of large restriction fragments of Mycobacterium avium isolates recovered from AIDS and non-AIDS patients with those of isolates from potable water. J. Clin. Microbiol. 37:1008-1012.[Abstract/Free Full Text]
2 - Bartos, M., P. Hlozek, P. Svastova, L. Dvorska, T. Bull, L. Matlova, I. Parmova, I. Kuhn, J. Stubbs, M. Moravkova, J. Kintr, V. Beran, I. Melicharek, M. Ocepek, and I. Pavlik. 2006. Identification of members of Mycobacterium avium species by Accu-Probes, serotyping, and single IS900, IS901, IS1245 and IS901-flanking region PCR with internal standards. J. Microbiol. Methods 64:333-345.[CrossRef][Medline]
3 - Bauer, J., A. B. Andersen, D. Askgaard, S. B. Giese, and B. Larsen. 1999. Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245. J. Clin. Microbiol. 37:600-605.[Abstract/Free Full Text]
4 - Beggs, M. L., R. Stevanova, and K. D. Eisenach. 2000. Species identification of Mycobacterium avium complex isolates by a variety of molecular techniques. J. Clin. Microbiol. 38:508-512.[Abstract/Free Full Text]
5 - Boddinghaus, B., T. Rogall, T. Flohr, H. Blocker, and E. C. Bottger. 1990. Detection and identification of mycobacteria by amplification of rRNA. J. Clin. Microbiol. 28:1751-1759.[Abstract/Free Full Text]
6 - De Smet, K. A., I. N. Brown, M. Yates, and J. Ivanyi. 1995. Ribosomal internal transcribed spacer sequences are identical among Mycobacterium avium-intracellulare complex isolates from AIDS patients, but vary among isolates from elderly pulmonary disease patients. Microbiology 141:2739-2747.[Abstract/Free Full Text]
7 - Dvorska, L., T. J. Bull, M. Bartos, L. Matlova, P. Svastova, R. T. Weston, J. Kintr, I. Parmova, D. van Soolingen, and I. Pavlik. 2003. A standardised restriction fragment length polymorphism (RFLP) method for typing Mycobacterium avium isolates links IS901 with virulence for birds. J. Microbiol. Methods 55:11-27.[CrossRef][Medline]
8 - Falkinham, J. O., III. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev. 9:177-215.[Free Full Text]
9 - Feller, M., K. Huwiler, R. Stephan, E. Altpeter, A. Shang, H. Furrer, G. E. Pfyffer, T. Jemmi, A. Baumgartner, and M. Egger. 2007. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 7:607-613.[CrossRef][Medline]
10 - Field, S. K., D. Fisher, and R. L. Cowie. 2004. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 126:566-581.[CrossRef][Medline]
11 - Fischer, O., L. Matlova, J. Bartl, L. Dvorska, I. Melicharek, and I. Pavlik. 2000. Findings of mycobacteria in insectivores and small rodents. Folia Microbiol. (Praha) 45:147-152.[CrossRef][Medline]
12 - Frothingham, R., and K. H. Wilson. 1993. Sequence-based differentiation of strains in the Mycobacterium avium complex. J. Bacteriol. 175:2818-2825.[Abstract/Free Full Text]
13 - Guerrero, C., C. Bernasconi, D. Burki, T. Bodmer, and A. Telenti. 1995. A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J. Clin. Microbiol. 33:304-307.[Abstract/Free Full Text]
14 - Hazra, R., S. H. Lee, J. N. Maslow, and R. N. Husson. 2000. Related strains of Mycobacterium avium cause disease in children with AIDS and in children with lymphadenitis. J. Infect. Dis. 181:1298-1303.[CrossRef][Medline]
15 - Ichiyama, S., K. Shimokata, and M. Tsukamura. 1988. The isolation of Mycobacterium avium complex from soil, water, and dusts. Microbiol. Immunol. 32:733-739.[Medline]
16 - Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.[Abstract/Free Full Text]
17 - Johansen, T. B., B. Djonne, M. R. Jensen, and I. Olsen. 2005. Distribution of IS1311 and IS1245 in Mycobacterium avium subspecies revisited. J. Clin. Microbiol. 43:2500-2502.[Abstract/Free Full Text]
18 - Kent, P. T., and G. P. Kubica. 1989. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
19 - Komijn, R. E., P. E. de Haas, M. M. Schneider, T. Eger, J. H. Nieuwenhuijs, R. J. van den Hoek, D. Bakker, F. G. Zijd Erveld, and D. van Soolingen. 1999. Prevalence of Mycobacterium avium in slaughter pigs in The Netherlands and comparison of IS1245 restriction fragment length polymorphism patterns of porcine and human isolates. J. Clin. Microbiol. 37:1254-1259.[Abstract/Free Full Text]
20 - Kunze, Z. M., F. Portaels, and J. J. McFadden. 1992. Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J. Clin. Microbiol. 30:2366-2372.[Abstract/Free Full Text]
21 - Kunze, Z. M., S. Wall, R. Appelberg, M. T. Silva, F. Portaels, and J. J. McFadden. 1991. IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol. Microbiol. 5:2265-2272.[Medline]
22 - Legrand, E., C. Sola, B. Verdol, and N. Rastogi. 2000. Genetic diversity of Mycobacterium avium recovered from AIDS patients in the Caribbean as studied by a consensus IS1245-RFLP method and pulsed-field gel electrophoresis. Res. Microbiol. 151:271-283.[Medline]
23 - Marsh, I., R. Whittington, and D. Cousins. 1999. PCR-restriction endonuclease analysis for identification and strain typing of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium based on polymorphisms in IS1311. Mol. Cell Probes 13:115-126.[CrossRef][Medline]
24 - Mazurek, G. H., S. Hartman, Y. Zhang, B. A. Brown, J. S. Hector, D. Murphy, and R. J. Wallace, Jr. 1993. Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J. Clin. Microbiol. 31:390-394.[Abstract/Free Full Text]
25 - Mijs, W., P. de Haas, R. Rossau, L. T. Van der, L. Rigouts, F. Portaels, and D. van Soolingen. 2002. Molecular evidence to support a proposal to reserve the designation Mycobacterium avium subsp. avium for bird-type isolates and "M. avium subsp. hominissuis" for the human/porcine type of M. avium. Int. J. Syst. Evol. Microbiol. 52:1505-1518.[Abstract]
26 - Novi, C., L. Rindi, N. Lari, and C. Garzelli. 2000. Molecular typing of Mycobacterium avium isolates by sequencing of the 16S-23S rDNA internal transcribed spacer and comparison with IS1245-based fingerprinting. J. Med. Microbiol. 49:1091-1095.[Abstract/Free Full Text]
27 - Pavlik, I., P. Svastova, J. Bartl, L. Dvorska, and I. Rychlik. 2000. Relationship between IS901 in the Mycobacterium avium complex strains isolated from birds, animals, humans, and the environment and virulence for poultry. Clin. Diagn. Lab. Immunol. 7:212-217.[CrossRef][Medline]
28 - Primm, T. P., C. A. Lucero, and J. O. Falkinham III. 2004. Health impacts of environmental mycobacteria. Clin. Microbiol. Rev. 17:98-106.[Abstract/Free Full Text]
29 - Ringuet, H., C. Akoua-Koffi, S. Honore, A. Varnerot, V. Vincent, P. Berche, J. L. Gaillard, and C. Pierre-Audigier. 1999. hsp65 sequencing for identification of rapidly growing mycobacteria. J. Clin. Microbiol. 37:852-857.[Abstract/Free Full Text]
30 - Ritacco, V., K. Kremer, L. T. Van der, J. E. Pijnenburg, P. E. de Haas, and D. van Soolingen. 1998. Use of IS901 and IS1245 in RFLP typing of Mycobacterium avium complex: relatedness among serovar reference strains, human and animal isolates. Int. J. Tuberc. Lung Dis. 2:242-251.[Medline]
31 - Roth, A., M. Fischer, M. E. Hamid, S. Michalke, W. Ludwig, and H. Mauch. 1998. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J. Clin. Microbiol. 36:139-147.[Abstract/Free Full Text]
32 - Runyon, E. H. 1967. Mycobacterium intracellulare. Am. Rev. Respir. Dis. 95:861-865.[Medline]
33 - Steed, K. A., and J. O. Falkinham, III. 2006. Effect of growth in biofilms on chlorine susceptibility of Mycobacterium avium and Mycobacterium intracellulare. Appl. Environ. Microbiol. 72:4007-4011.[Abstract/Free Full Text]
34 - Tacquet, A., and F. Tison. 1961. Nouvelle technique d'isolement des mycobacteries par le lauryl sulfate de sodium. Ann. de l'Institut Pasteur. 100:676-680. (In French.)
35 - Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bottger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.[Abstract/Free Full Text]
36 - Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Free Full Text]
37 - Thorel, M. F., M. Krichevsky, and V. V. Levy-Frebault. 1990. Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int. J. Syst. Bacteriol. 40:254-260.[Abstract/Free Full Text]
38 - Tobin-D'Angelo, M. J., M. A. Blass, C. del Rio, J. S. Halvosa, H. M. Blumberg, and C. R. Horsburgh, Jr. 2004. Hospital water as a source of Mycobacterium avium complex isolates in respiratory specimens. J. Infect. Dis. 189:98-104.[CrossRef][Medline]
39 - Turenne, C. Y., M. Semret, D. V. Cousins, D. M. Collins, and M. A. Behr. 2006. Sequencing of hsp65 distinguishes among subsets of the Mycobacterium avium complex. J. Clin. Microbiol. 44:433-440.[Abstract/Free Full Text]
40 - van Soolingen, D., J. Bauer, V. Ritacco, S. C. Leao, I. Pavlik, V. Vincent, N. Rastogi, A. Gori, T. Bodmer, C. Garzelli, and M. J. Garcia. 1998. IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J. Clin. Microbiol. 36:3051-3054.[Abstract/Free Full Text]
41 - von Reyn, C. F., J. N. Maslow, T. W. Barber, J. O. Falkinham, III, and R. D. Arbeit. 1994. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 343:1137-1141.[CrossRef][Medline]
42 - Wayne, L. G., R. C. Good, A. Tsang, R. Butler, D. Dawson, D. Groothuis, W. Gross, J. Hawkins, J. Kilburn, M. Kubin, et al. 1993. Serovar determination and molecular taxonomic correlation in Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum: a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int. J. Syst. Bacteriol. 43:482-489.[Abstract/Free Full Text]
43 - Wilton, S., and D. Cousins. 1992. Detection and identification of multiple mycobacterial pathogens by DNA amplification in a single tube. PCR Methods Appl. 1:269-273.[Medline]
Journal of Clinical Microbiology, April 2008, p. 1246-1251, Vol. 46, No. 4
0095-1137/08/$08.00+0 doi:10.1128/JCM.01621-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Ichikawa, K., Yagi, T., Moriyama, M., Inagaki, T., Nakagawa, T., Uchiya, K.-I., Nikai, T., Ogawa, K.
(2009). Characterization of Mycobacterium avium clinical isolates in Japan using subspecies-specific insertion sequences, and identification of a new insertion sequence, ISMav6. J Med Microbiol
58: 945-950
[Abstract]
[Full Text]